Resveratrol STUDIES

Highlights Randomized, double-blind, controlled, cross-over with 20 adults with hypertension Supplementation consisted of single doses of resVida® (30, 90 and 270 mg) All amounts of resVida® significantly improve endothelial function...

Highlights Meta-analysis of 17 randomized, controlled trials (736 participants) Resveratrol supplementation significantly reduces TNF-alpha and C-reactive protein Median dosage is 300 mg/day for 2 months   Summary This meta-analysis was performed...

Highlights Meta-analysis with 11 randomized, controlled clinical trials comprising 388 subjects In people with diabetes, resveratrol significantly improves glucose control and insulin sensitivity. Median intake is 100 mg/day for 12...

Highlights Randomized, double-blind, placebo-controlled trial with 56 adults with mild-to-moderate ulcerative colitis Supplementation consists of trans-resveratrol (500 mg/day) for 6 weeks Resveratrol significantly increases body’s antioxidant status, reduces disease activity and improves...

Highlights Randomized, double-blind, placebo-controlled, cross-over trial with 22 healthy adults Supplementation consists of single doses of 99% pure trans-resveratrol (250 mg or 500 mg) Resveratrol increases cerebral blood flow during cognitive performance, compared to...